MedPath

The Effects of Ketone Ester Supplementation During a 5 Week Live High, Train Low Altitude Training Camp

Not Applicable
Recruiting
Conditions
Hypoxia
Exogenous Ketosis
Interventions
Dietary Supplement: Placebo supplement
Dietary Supplement: Ketone ester supplement
Registration Number
NCT06596083
Lead Sponsor
KU Leuven
Brief Summary

This study aims to investigate the effects of post-exercise and pre-sleep exogenous ketosis via oral ketone ester supplementation during a 5 week simulated altitude training camp.

Detailed Description

Altitude training camps, where you train at sea level but live at altitude, have become a popular way for athletes to prepare for upcoming races or events. The main aim of such training camps is to benefit from the adaptations following prolonged hypoxic exposure (increased EPO concentrations leading to an increase in oxygen carrying capacity in the blood). Recently, ketone bodies have been shown to cause similar adaptations. Therefore, this study aims to investigate whether the combination of exogenous ketosis and an altitude training camp is more beneficial compared to an altitude training camp on its own.

Participants will follow a 5 week simulated altitude training camp where they spend 75 hours per week at altitude (2000-3000 meters), while taking ketone or placebo supplements after every training sessions and before going to sleep. During these 5 weeks, they will adhere to a prescribed training plan, consisting of 5 to 7 training sessions per week. Before, after and 1 week after the training camp, their exercise performance, EPO concentrations, hemoglobin mass and VO2max will be tested.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Physically fit and regularly involved in physical activity (2-5h per week)
  • Good health status confirmed by a medical screening
  • Non-smoking
Read More
Exclusion Criteria
  • Any kind of injury/pathology that is a contra-indication to perform high-intensity exercise
  • Any kind of injury/pathology that is a contra-indication for exposure to hypoxia
  • Ongoing pregnancy or breastfeeding
  • intake of any medication or nutritional supplement that is proven to affect exercise performance during the last month prior to the start of the study
  • Involvement in elite athletic training at a semi-professional or professional level
  • Exposure to altitudes higher than 1500 m during the 3 months prior to the start of the study
  • Blood ferritin levels below 30 ng/mL
  • Current participation in another research trial
  • Any other argument to believe that the subject is unlikely to succesfully complete the full study protocol
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo ComparatorPlacebo supplementTraining intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: placebo supplement
Experimental groupKetone ester supplementTraining intervention: 5 weeks of live high, train low followed by an additional 1 week of reduced training (to simulate preparation for an upcoming event or race) Dietary intervention: Ketone ester supplement
Primary Outcome Measures
NameTimeMethod
Total hemoglobin massDay 0, Day 35, Day 42

Using the optimized CO-re-breathing method, total hemoglobin mass will be estimated

Skeletal muscle capillarizationDay 0, Day 35, Day 42

Changes in muscle capillarization are measured using immunohistochemical anlyses

Cycling exercise performanceDay 0, Day 35, Day 42

maximal average power output during a 30 minute time trial, cycling efficiency test and repeated sprint test

Secondary Outcome Measures
NameTimeMethod
Maximal oxygen uptake (VO2max)Day 0, Day 35, Day 42

Using ergospirometry VO2max will be measured during a graded exercise test

Change in peripheral blood flowDay 0, Day 35, Day 42

Measured using duplex ultrasonography

Serum EPO concentrationsDay 0, day1, week1, week2, week3, week4, week5, day35, day42

Serum EPO concentrations will be measured using a commercially available ELISA kit

Sleep ArchitectureDay 0, day1, week 3, day35, day42

Polysomnography will be used to measure sleep architecture

Trial Locations

Locations (1)

KU Leuven

🇧🇪

Leuven, Vlaams-Brabant, Belgium

© Copyright 2025. All Rights Reserved by MedPath